Johnson Matthey Inc. has recalled approximately 396,210 units (over 395,000 grams) of three active pharmaceutical ingredients: Fentanyl Citrate, Cisplatin, and Oxaliplatin. These products, which are used to manufacture finished medications for pain and cancer treatment, were found to have potential glass contamination due to manufacturing deviations. Consumers and healthcare providers should be aware that these ingredients were distributed nationwide across the United States.
The presence of glass fragments in injectable or oral medications can lead to serious health complications, including internal irritation, inflammation, or trauma to the site of administration. No specific injuries have been reported in the provided data, but the contamination represents a significant manufacturing failure.
Contact healthcare provider and return for refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.